Top High Tech Companies To Buy Right Now

Top High Tech Companies To Buy Right Now: KMG Chemicals Inc (KMG)

KMG Chemicals, Inc., incorporated on July 30, 1992, manufactures, formulates and globally distributes specialty chemicals. The Company has acquired and operates businesses selling electronic chemicals and industrial wood treating chemicals. The Company operates in two segments: electronic chemicals and wood treating chemicals. The Company's electronic chemicals segment provides wet process chemicals to the semiconductor industry, primarily to clean and etch silicon wafers in the production of semiconductors. The Company supplies wet process chemicals to the semiconductor industry in the United States and Europe. Its wood treating chemicals, pentachlorophenol (penta), and creosote, are sold to industrial customers who use these preservatives primarily to extend the useful life of utility poles and railroad crossties. The Company is the supplier of penta in North America, and supplier of creosote in the United States to wood treaters who do not produce their own creosote. On March 1, 2012, the Company discontinued its animal health business. In June 2013, the Company announced that it completed the acquisition of the Ultra Pure Chemicals subsidiaries of OM Group Inc located in the United States, England and Singapore.

Electronic Chemicals

The Company's electronic chemicals business sells wet process chemicals primarily to the semiconductor industry. These chemicals are used to clean and etch silicon wafers in the production of semiconductors. The Company's products include sulfuric, phosphoric, nitric and hydrofluoric acids, ammonium hydroxide, hydrogen peroxide, isopropyl alcohol and various blends of chemicals. The Company's products are sold in bulk and in containers, including bottles, drums and totes. This process is accomplished at the Company's Pueblo, Colorado, Hollister, California and Milan, Italy facil! ities, although the Company contracts with General Chemical to produce certain products for the Company at its facility. As of July 31, 2012, the Company's electronic ! chemicals business accounted for 58.5% of its net sales.

Wood Treating Chemicals

The Company supplies penta and creosote to industrial customers who use these products to extend the useful life of wood, primarily utility poles and railroad crossties. The Company's penta products include penta blocks, solutions and hydrochloric acid, a byproduct of penta production. Penta is used primarily to treat utility poles, protecting them from insect damage and decay. The Company manufactures solid penta blocks at its facility in Matamoros, Mexico. The Company sells solid penta to its customers, or make it into a liquid solution of penta concentrate at its Matamoros, Mexico and Tuscaloosa, Alabama facilities. The Company sells penta products primarily in the southeastern and northwestern United States and in Canada. The hydrochloric acid the Company produces as a byproduct of penta production is sold in Mexico for use in the steel and oils well service industr ies. Creosote is a wood preservative used to treat utility poles and railroad crossties. Creosote is produced by the distillation of coal tar, a by-product of the transformation of coal into coke. The Company sells creosote to wood treaters throughout the United States. As of July 31, 2012, the Company's wood treating chemicals constituted about 41.4% of the Company's net sales.

The Company competes with Honeywell, Kanto Corporation, Avantor, BASF and the OM Group.

Advisors' Opinion:

• [By Monica Gerson]

  KMG Chemicals (NYSE: KMG) is projected to report its Q4 earnings.

  JB Hunt Transport Services (NASDAQ: JBHT) is expected to report its Q3 earnings at $0.84 per share on revenue of $1.59 billion.

• [By Monica Gerson]

  KMG Chemicals (NYSE: KMG) is expected to report its Q4 earnings at $0.27 per s! hare on r! evenue of $79.00 million.

  Brown & Brown (NYSE: BRO) is projected to post its Q3 earnings at $0.40 per share on revenue of $348.85 million.

• [By Monica Gerson]

  Analysts expect KMG Chemicals (NYSE: KMG) to report its Q4 earnings at $0.27 per share on revenue of $79.00 million. KMG Chemicals shares surged 4.99% to close at $23.76 on Friday.

• [By Rich Smith]

  KMG Chemicals (NYSE: KMG  ) is buying OM Group's (NYSE: OMG  ) Ultra Pure Chemicals subsidiaries in the U.S., U.K., Singapore, and perhaps in France as well.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-high-tech-companies-to-buy-right-now-3.html

Top 10 Asian Companies To Watch In Right Now

Top 10 Asian Companies To Watch In Right Now: Dj Wilshire Reit Etf (RWR)

SPDR DJ Wilshire REIT (the Fund), formerly DJ Wilshire REIT ETF, seeks to replicate as closely as possible the performance of the Dow Jones Wilshire REIT Index (the Index). The Fund utilizes a passive or indexing approach, and attempts to approximate the investment performance of its Index, by investing in a portfolio of stocks to replicate the Index. The Index seeks to provide an effective representation of the United States real estate investment trust (REIT) market.

The Index consists of companies whose charters are the equity ownership and operation of commercial real estate, and which operate under the REIT Act of 1960. The Index is generally rebalanced monthly. Companies are chosen based upon market capitalization, source of revenue and liquidity. Each REIT in the Index is weighted by its float-adjusted market capitalization. The Fund's investment manager is SSgA Funds Management, Inc.

Advisors' Opinion:

• [By Chuck Saletta]

  Where to invest?
  There are countless possibilities for building your retirement portfolio to cover Social Security's gap, depending on your personal risk tolerance, timeline, and need for cash. Here are decent index-style ETFs across various asset types to consider when building your plan:

  Domestic stocks. The Vanguard Total Market (NYSEMKT: VTI  ) ETF is a one-stop-shop that gives you access to around 99.5% by market cap of the publicly held U.S. stocks traded on major exchanges. A mere 3% turnover and microscopically low 0.05% expense ratio makes this a low-cost way to invest in the overall stock market. Investment-grade bonds. The iShares iBoxx $Invest Grade Corp Bond   (NYSEMKT: LQD  ) ETF owns nearly $24 billion worth of investment-grade corporate bonds. A small 4% turnover and low 0.15% expense ratio make this a low-c! ost way to get bond exposure. Real estate. The SPDR Dow Jones REIT (NYSEMKT: RWR  ) ETF has a bit over $2 billion invested in real estate investment trusts, attempting to match the Dow Jones Select REIT index. With a reasonable 7% turnover and a still pretty low 0.25% expense ratio, this is a reasonable way to get real estate exposure without turning yourself into a landlord. Foreign stocks. Vanguard's Total International Stock Index (NASDAQ: VXUS  ) ETF has nearly $90 billion in foreign stocks under its control, owning pieces of more than 6,100 stocks from 45 countries. With a mere 3% turnover and low 0.16% expense ratio, it's one of the lowest-cost ways to get your hands on foreign companies without being an international accounting expert. Inflation-protected government bonds. The iShares Barclays TIPS Bond (NYSEMKT: TIP  ) ETF has around $20 billion invested in U.S. Treasury inflation-protected bonds. With a low expense ratio of 0.2% and a reasonable 10% turnover rate, it's a decent way to get exposure to inflation-protected bonds. Note, though, that
• [By Hilary Kramer]

   

  2. Real Estate Investment Trusts (REITs) The REIT is another alternative vehicle that's gone mainstream in recent years. Hundreds of broad-based and specialized real estate companies and ETFs are available, and after a correction a few months ago, many are on the cheap side. Like any other alternative, this should be a seasoning for your portfolio and not the sauce itself. For most retail investors, a stake in an indexed fund like the SPDR Dow Jones REIT (NYSE: RWR) should be more than adequate, or look into the companies that provide services to the REIT industry like HFF (NYSE: HF) and Jones Lang LaSalle (NYSE: JLL).

   

source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-asian-companies-to-watch-in-right-now-3.html

Top European Stocks To Invest In 2014

It's been years -- centuries, really -- since Viking longships were last sighted off the shores of Britain. But they're coming back, and this time, they have Amazon.com (NASDAQ: AMZN  ) as an ally.

On Friday, Amazon announced that its European LOVEFiLM subsidiary is teaming up with MGM (NYSE: MGM  ) Television to bring the hit new History Channel television show VIKINGS to viewers in the U.K., and Germany as well. Beginning May 24, LOVEFiLM will be the only service offering streaming video of all nine episodes of Vikings' first season to viewers in the U.K. and Germany. (Season 2 is scheduled to arrive in 2014). Additionally, Amazon points out that it will be streaming the show through LOVEFiLM before Vikings even goes into broadcast in Europe.

History Channel is a property of A&E Networks, a joint venture between Hearst Corporation and Disney's (NYSE: DIS  ) ABC.

MGM has the international distribution rights to Vikings outside the U.S., Canada, and Ireland.

5 Best Gas Stocks To Invest In Right Now: Aercap Holdings N.V. (AER)

AerCap Holdings N.V., through its subsidiaries, operates as an integrated aviation company worldwide. It engages in leasing and trading aircraft and engines; and selling parts. The company also provides aircraft management services, as well as aircraft and limited engine MRO services, and aircraft disassembly services through its repair stations. In addition, it offers aircraft services, including remarketing aircraft; collecting rental and maintenance payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft; conducting ongoing lessee financial performance reviews; inspecting the leased aircraft; coordinating technical modifications to aircraft to meet new lessee requirements; conducting restructurings negotiations in connection with lease defaults; repossessing aircraft; arranging and monitoring insurance coverage; registering and de-registering aircraft; arranging for aircraft and aircraft engine valuations; and providing market research. The company?s management services include leasing and remarketing, cash management and treasury, technical advisory, and accounting and administrative services. As of March 31, 2011, it owned 272 aircraft and 95 engines, which it leased under operating leases to 118 lessees in 53 countries. The company was founded in 1995 and is headquartered in Schiphol, the Netherlands.

Advisors' Opinion:

• [By John Udovich]

  Yesterday around midday,�Netherlands based aviation leasing stock�AerCap Holdings N.V. (NYSE: AER) began surging on rumors and closed up 11.6%, meaning its probably time to take a closer look at those rumors along with aviation leasing peers like small caps or mid caps�Aircastle Limited (NYSE: AYR), Air Lease Corp (NYSE: AL), Fly Leasing Ltd (NYSE: FLY) and AeroCentury Corp (NYSEMKT: ACY).

• [By Paul Ausick]

  More than two years ago, American International Group Inc. (NYSE: AIG) filed with the U.S. Securities and Exchange Commission for an initial public offering (IPO) in its aircraft leasing group, International Lease Finance Corp. (ILFC). That filing came to nothing, and AIG found little interest from buyers for ILFC, until Monday morning when it announced that AerCap Holdings N.V. (NYSE: AER) will buy the leasing operation for $3 billion in cash and 97.56 million shares of new AerCap stock. The total value of the deal is approximately $5.4 billion.

Top European Stocks To Invest In 2014: Fresenius Medical Care Corporation (FMS)

Fresenius Medical Care AG & Co. KGaA, a dialysis company, provides products and services for patients with chronic kidney diseases. As of May 12, 2011, it provided dialysis care services to 216,942 patients through its network of 2,769 dialysis clinics primarily in North America, Europe, Latin America, the Asia-Pacific, and Africa. The company also develops and manufactures various dialysis products, including hemodialysis machines, dialyzers, hemofilters, dialysis fluid filters, tubing systems, fistula needles, dialysis related equipment, acute hemodialysis machines, plasma filters, acute tubing systems and cassettes, catheters, and related disposable products for chronic hemodialysis, acute therapy, home therapy, and therapeutic apheresis, as well as dialysis drugs. In addition, it provides laboratory services. Fresenius Medical sells its products through distributors. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

Advisors' Opinion:

• [By John Udovich]

  Small cap dialysis stock Rockwell Medical Inc (NASDAQ: RMTI) looks set to decline when the market opens after Brean Capital initiated coverage with a sell rating and a price target of $4.00, meaning it might be time to take a closer look at what is going on with the stock along with�the performance of large cap dialysis stocks DaVita Healthcare Partners (NYSE: DVA)�and Fresenius Medical Care (NYSE: FMS) along with small cap dialysis stocks NxStage Medical, Inc (NASDAQ: NXTM).�

Top European Stocks To Invest In 2014: STMicroelectronics N.V.(STM)

STMicroelectronics N.V., an independent semiconductor company, engages in the design, development, manufacture, and marketing of a range of semiconductor integrated circuits and discrete devices. Its products include discrete and standard commodity components, application-specific integrated circuits, custom devices and semi-custom devices, and application-specific standard products for analog, digital, and mixed-signal applications. The company also offers subsystems and modules for the telecommunications, automotive, and industrial markets comprising mobile phone accessories, battery chargers, ISDN power supplies, and in-vehicle equipment for electronic toll payment, as well as provides Smartcard products. Its products are used in various microelectronic applications consisting of automotive products, computer peripherals, telecommunications systems, consumer products, industrial automation, and control systems. The company sells its products through distributors and ret ailers. STMicroelectronics N.V. was founded in 1987 and is headquartered in Geneva, Switzerland.

Advisors' Opinion:

• [By Tyler Laundon]

  Analog Devices (ADI) is one of the largest semiconductor companies in the motion-sensing space, with a market cap of $15.87 billion. STM Electronics (STM) is a slightly smaller manufacturer; its market cap is $7.6 billion.

• [By MONEYMORNING]

  In 2009, Ericsson hooked up with STMicroelectronics NV (NYSE ADR: STM) - Europe's No. 1 chipmaker - to produce semiconductors for the wireless market. Launched in 2009, this also was ill-fated.

• [By Tim Brugger]

  In addition to the upgraded Atom processor rollout, Intel also announced a realignment of its management structure. Now comes word the "leading semiconductor company" named in a recent press release announcing the acquisition of a STMicroelectronics (NYSE: STM  ) and Ericsson (NASDAQ: ERIC  ) mobile GPS joint venture was none other than Intel. When Krzanich said he was committed to the rapidly changing mobile computing market, he wasn't kidding; and that should be sweet music to the ears of Intel shareholders.

• [By Dan Burrows]

  Additionally, Wendy’s can use some of the cash freed up by the franchise model to invest in advertising and marketing, and that should boost customer traffic.

  Cheap Dividend Stocks #2: STMicroelectronics (STM)

  Share Price as of 4/4: $9.14
  YTD Stock Performance: 14%
  Dividend Yield: 4.4%

Top European Stocks To Invest In 2014: TotalFinaElf S.A.(TOT)

TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.

Advisors' Opinion:

• [By Ben Levisohn]

  Howard Weil’s Blake Fernandez�explains why he prefers ConocoPhillips to�other oil companies like Total (TOT) and�Chevron�(CVX):

  After years of portfolio rationalization, concerns re: dividend coverage, etc. the asset base is now poised to deliver 6- 10% cash flow CAGR through ��7 from a combination of 3-5% production growth and 3-5% margin expansion. Additionally, our confidence in the Company�� unconventional prowess is increasing based on the recent analyst day presentation, higher production targets and efficiency gains in the underlying assets…

• [By Dan Burrows]

  At the same time, RAI is forecast to have strong earnings growth this year and beyond. Wall Street expects earnings per share (EPS) to expand 6% in the current fiscal year, and by more than 8% in 2015. That should be more than enough growth and income to drive more total return outperformance this year and beyond.

  Total (TOT)

  Dividend Yield: 5.1%
  1-Year Total Return: 41%

Top European Stocks To Invest In 2014: BP p.l.c.(BP)

BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission sys tem pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The company?s Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.

Advisors' Opinion:

• [By Oil and Gas Investments Bulletin]

  But with all the majors who've signed up for Canadian LNG -- Chevron (CVX), Apache (APA), Shell (RDS.A), BP (BP), and most recently Malaysian major Petronas (PNADF.OB) announcing it will invest $20 billion to develop its Pacific Northwest LNG project near Prince Rupert -- we're talking about a development almost unprecedented in our petroleum sector.

Top European Stocks To Invest In 2014: Telefonica SA(TEF)

Telefonica, S.A. provides fixed and mobile telephony services primarily in Spain, rest of Europe, and Latin America. Its fixed telecommunication services include PSTN lines; ISDN accesses; public telephone; local, domestic, and international long distance and fixed-to-mobile communications; corporate communications; video telephony; supplementary and business-oriented value-added services; network services; leasing and sale of handset equipment; and telephony information services. The company?s Internet and broadband multimedia services comprise Internet service provider service; portal and network services; retail and wholesale broadband access; narrowband switched access to Internet; naked ADSL, a broadband connection; residential-oriented value-added services; companies-oriented value-added services; television services, such as IPTV, cable television, and satellite television; and Fiber to the Home, a service for high speed Internet access and digital video recording. Its data and business-solutions services principally include leased lines; virtual private network services; fiber optics services; the provision of hosting and application; outsourcing and consultancy services; desktop services; and system integration and professional services. The company?s wholesale services for telecommunication operators primarily comprise domestic interconnection services; international wholesale services; leased lines for other operators? network deployment; local loop leasing under the unbundled local loop regulation framework; and bit stream services. It also offers various mobile and related services and products that include mobile voice services, value added services, mobile data and Internet services, wholesale services, corporate services, roaming, fixed wireless, and trunking and paging services. The company has a strategic alliance with China Unicom (Hong Kong) Limited. Telefonica, S.A. was founded in 1924 and is headquartered in Madrid, Spai n.

Advisors' Opinion:

• [By Charles Sizemore]

  So, what does this mean for AMX stock and for its largest single competitor in Latin America, Spain��Telefonica (TEF)?

  To start, this will, by default, massively diversify AMX�� revenue stream globally. Though AMX is the number-one or number-two mobile provider in nearly every Latin American country, its home market of Mexico is by far its biggest. Mexico currently accounts for about a third of sales and nearly half of profits. The new AMX will be a pan-Latin-American telecom giant based in Mexico rather than a Mexican telecom giant with operations in Central and South America.

• [By Charles Sizemore]

  Next Page

  European Dividend Stocks to Buy: Telefonica (TEF)

  Dividend Yield: 6%

  And finally, we get to one of my favorite long-term holdings, Spanish telecom giant Telefonica (TEF).

• [By Dan Caplinger]

  Working with incomplete information is something markets are used to, though, despite the volatility that it can produce. AT&T (NYSE: T  ) posted minimal gains after Spain's Telefonica (NYSE: TEF  ) denied rumors that AT&T was looking to buy out the European telecom giant. With its already massive position in the U.S. wireless market, AT&T will have to look abroad for substantial growth opportunities. With Telefonica having chosen to cut its dividend temporarily in order to reallocate capital, a buyout might have been good news for its shareholders; Telefonica stock is up 3.5% despite its denial. Still, given the amount of money involved -- $93 billion, according to one report -- it would take a massive commitment to get the deal done.

Hot Gas Companies To Watch In Right Now

Cummins Inc. (CMI) announced a 25% increase in its quarterly dividend to 62.50 cents per share from 50 cents. The company will pay the cash dividend on Sep 3, 2013 to shareholders of record as on Aug 22, 2013. Following the announcement, shares of Cummins increased 1.62% to close at $112.62 on Jul 9.

Last year in July, Cummins had increased its quarterly dividend by 25% to 50 cents per share from 40 cents, which was paid on Sep 1, 2012. With this hike, the company has now increased its dividend by 257% over the last four years.

In Dec 2012, Cummins also announced the share repurchase program of up to $1 billion. The company expects that these shareholder-friendly moves will enhance the company�� shareholders value.

Cummins is a leading worldwide designer, manufacturer and distributor of diesel and natural gas engines, electric power generation systems, and engine-related components, fuel systems, controls and air handling systems. Currently, the company retains a Zacks Rank #4 (Sell).

Best Chemical Stocks To Own Right Now: Athlon Energy Inc (ATHL)

Athlon Energy Inc., incorporated on April 1, 2013, is an independent exploration and production company. The Company is a holding company and its sole assets are controlling equity interests in Athlon Holdings LP and its subsidiaries. The Company is focused on the acquisition, development and exploitation of unconventional oil and liquids-rich natural gas reserves in the Permian Basin. The Permian Basin spans portions of Texas and New Mexico and consists of three primary sub-basins: the Delaware Basin, the Central Basin Platform and the Midland Basin. The Company�� properties are located in the Midland Basin. Its drilling activity is focused on the vertical development of stacked pay zones, including the Spraberry, Wolfcamp, Cline, Strawn, Atoka and Mississippian formations, which it refers to collectively as the Wolfberry play. The Company's acreage position was 124,925 gross at May 31, 2013, which it grousp into three primary areas based on geographic location within the Midland Basin: Howard, Midland and Other and Glasscock. As of April 30, 2013, the Company operated up to eight vertical drilling rigs and has drilled 218 gross operated vertical Wolfberry wells. In February 2014, Athlon Energy Inc announced that subsidiary, Athlon Holdings LP completed the acquisition of certain oil and natural gas properties and related assets in the Midland Basin of West Texas.

As of March 15, 2013, there were 478 total rigs operating in the Permian Basin. The Company�� properties are located within the Midland Basin in areas with approximately 3,000 feet to 4,000 feet of stacked pay zones. Its vertical drilling program is targeting the Spraberry, Wolfcamp, Cline, Strawn, Atoka and Mississippian formations.

Howard

The Company operates four rigs in this area. As of May 31, 2013, the Company had 69,661 gross acres and an inventory of 1,577 gross (1,140 net) identified vertical drilling locations on 40-acre spacing and an additional 1,741 gross identified vertical drilling ! locations on 20-acre spacing. As of April 30, 2013, it had identified 506 gross horizontal drilling locations consisting of 147 gross Wolfcamp A locations, 172 gross Wolfcamp B locations, 25 gross Wolfcamp C locations, 111 gross Cline locations and 51 gross Mississippian locations.

Midland and Other

The Company operates two rigs in this area. As of May 31, 2013, the Company had 36,694 gross acres and an inventory of 424 gross (390 net) identified vertical drilling locations on 40-acre spacing and an additional 463 gross (414 net) identified vertical drilling locations on 20-acre spacing. As of April 30, 2013, it has identified 352 gross horizontal drilling locations consisting of 64 gross Wolfcamp A locations, 125 gross Wolfcamp B locations, 97 gross Wolfcamp C locations and 66 gross Cline locations.

Glasscock

The Company operates one rig in this area. As of May 31, 2013, it had 18,570 gross net acres and an inventory of 297 gross (267 net) identified vertical drilling locations on 40-acre spacing and an additional 400 gross identified vertical drilling locations on 20-acre spacing. As of April 30, 2013, it had identified 232 gross horizontal drilling locations consisting of 54 gross Wolfcamp A locations, 58 gross Wolfcamp B locations, 58 gross Wolfcamp C locations and 62 gross Cline locations.

Advisors' Opinion:

• [By Matt Jarzemsky var popups = dojo.query(".socialByline .popC"); popups.forEach]

  The drillers considered to be Parsley�� closest peers include Diamondback Energy Inc.(FANG), which has seen its shares rally 38% so far this year through Thursday. Athlon Energy Inc.(ATHL), another similar company, is up 43% this year and 116% since its August IPO.

Hot Gas Companies To Watch In Right Now: Whitecap Resources Inc (SPGYF.PK)

Whitecap Resources Inc., formerly Spitfire Energy Ltd., is engaged in the exploration, development and production of crude oil, natural gas and natural gas liquids in Western Canada. The Company�� activities are concentrated primarily in Northwest Central Alberta and Southwest Saskatchewan. On July 1, 2010, the Company amalgamated with its wholly owned subsidiary Whitecap Resources Inc. During fiscal 2010, the Company produced an average of 355 barrels of oil equivalent per day (boed). On July 12, 2010, the Company entered into an agreement to acquire a private company. The primary assets to be acquired are located in the Pembina region of west central Alberta with production and reserves focused in the Cardium formation. In October 2013, the Company announced that it has completed the acquisition of a Cardium light oil property and a working interest consolidation of its Eagle Lake Viking unit. Advisors' Opinion:

• [By Caiman Valores]

  The recent surge in oil prices has renewed investor interest in the small-cap oil and gas E&P sector. One company that stands out for all the right reasons is Canadian domiciled small-cap, Whitecap Resources (SPGYF.PK). Since 2009 the company has unlocked considerable value for investors through a range of acquisitions as well as development and exploration projects. This has seen its share price surge in value to be up by almost 53% over the last year alone. However, it is clear that the market has yet to fully recognize the true value of Whitecap and there is still considerable upside potential of over 30% for investors. This along with Whitecap's dividend growth strategy makes it a particularly appealing deep-value investment in the oil and gas E&P sector.

Hot Gas Companies To Watch In Right Now: EV Energy Partners LP (EVEP)

EV Energy Partners, L.P. (the Partnership) is engaged in the acquisition, development and production of oil and natural gas properties. As of December 31, 2011, the Company's properties were located in the Barnett Shale, the Appalachian Basin (which includes the Utica Shale), the Mid Continent areas in Oklahoma, Texas, Arkansas, Kansas and Louisiana, the San Juan Basin, the Monroe Field in Northern Louisiana, the Permian Basin, Central and East Texas (which includes the Austin Chalk area), and Michigan. On November 1, 2011, the Company acquired oil and natural gas properties in the Mid Continent area. On December 1, 2011, the Company along with certain institutional partnerships managed by EnerVest, acquired oil and natural gas properties in the Barnett Shale. It acquired a 31.02% proportional interest in these properties. On December 20, 2011, the Company, along with certain institutional partnerships managed by EnerVest, acquired additional oil and natural gas properties in the Barnett Shale. It acquired a 31.63% proportional interest in these properties. On February 7, 2012, the Company along with certain institutional partnerships managed by EnerVest, had a second closing on the oil and natural gas properties, and acquired a 31.63% proportional interest in these properties.

Barnett Shale

The Barnett Shale properties are located in Denton, Parker, Tarrant and Wise counties in Northern Texas. Its portion of the estimated net proved reserves as of December 31, 2011, was 647.4 one billion cubic feet equivalent (Bcfe), 72% of which is natural gas. During 2011, the Company drilled 35 wells. EnerVest operates wells representing 100% of its estimated net proved reserves in this area, and the Company owns an average 29% working interest in 976 gross productive wells.

Appalachian Basin

The Company�� activities are concentrated in the Ohio and West Virginia areas of the Appalachian Basin. Its Ohio area properties are producing from the Knox and Clinton f! ormations and other Devonian age sands in 41 counties in Eastern Ohio and 11 counties in Western Pennsylvania. Its West Virginia area properties are producing from the Balltown, Benson and Big Injun formations in 23 counties in North Central West Virginia. Its estimated net proved reserves as of December 31, 2011, were 126.4 Bcfe, 76% of which is natural gas. During 2011, it drilled 33 grosswells, 26 of which were completed. EnerVest operates wells representing 92% of its estimated net proved reserves in this area, and it owns an average 41% working interest in 8,670 gross productive wells.

Mid-Continent Area

The properties are located in 47 counties in Oklahoma, 17 counties in Texas, four parishes in North Louisiana, one county in Kansas and six counties in Arkansas. The Company�� estimated net proved reserves as of December 31, 2011, were 81.2 Bcfe, 63% of which is natural gas. During 2011, it drilled 82 wells, all of which were completed. EnerVest operates wells representing 33% of its estimated net proved reserves in this area, and it owns an average 12% working interest in 1,864 gross productive wells.

San Juan Basin

The properties are located in Rio Arriba County, New Mexico and La Plata County in Colorado. The Company�� estimated net proved reserves as of December 31, 2011, 68.6 Bcfe, 59% of which is natural gas. During 2011, it drilled two wells, one of which were completed. EnerVest operates wells representing 94% of its estimated net proved reserves in this area, and it owns an average 71% working interest in 227 gross productive wells.

Monroe Field

The properties are located in two parishes in Northeast Louisiana. The Company�� estimated net proved reserves as of December 31, 2011, were 60.9 Bcfe, 100% of which is natural gas. During 2011, it drilled one well, which was completed. EnerVest operates wells representing 100% of its estimated net proved reserves in this area, and it owns an average 100% working i! nterest i! n 3,930 gross productive wells.

Permian Basin

The properties are located in the Yates, Seven Rivers, Queen, Morrow, Clear Fork and Wichita Albany formations in four counties in New Mexico and Texas. The Company�� estimated net proved reserves as of December 31, 2011, were 54.1Bcfe, 37% of which is natural gas. During 2011, it did not drill any wells. EnerVest operates wells representing 99% of its estimated net proved reserves in this area, and it owns an average 93% working interest in 160 gross productive wells.

Central and East Texas

The properties produce primarily from the Austin Chalk formation and are located in 30 counties in Central and East Texas. Its portion of the estimated net proved reserves as of December 31, 2011 was 60.9 Bcfe, 46% of which is natural gas. During 2011, the Company drilled 16 gross wells, 15 of which were completed. EnerVest operates wells representing 93% of its estimated net proved reserves in this area, and it owns an average 12% working interest in 1,829 gross productive wells.

Michigan

The properties are located in the Antrim Shale reservoir in Otsego and Montmorency counties in northern Michigan. The Company�� estimated net proved reserves as of December 31, 2011, were 44.9 Bcfe, 100% of which is natural gas. During 2011, it did not drill any wells. EnerVest operates wells representing 99% of its estimated net proved reserves in this area, and it has an average 84% working interest in 370 gross productive wells.

Advisors' Opinion:

• [By Robert Rapier]

  VNR is one of 14 companies/partnerships that are categorized as exploration and production, or ��pstream.��Other notable entries in this category include BreitBurn Energy Partners (Nasdaq: BBEP), Linn Energy (Nasdaq: LINE), Memorial Production Partners (Nasdaq: MEMP), QR Energy (NYSE: QRE), Legacy Reserves (Nasdaq: LGCY), EV Energy Partners (Nasdaq: EVEP), and Mid-Con Energy Partners (Nasdaq: MCEP).

• [By Matt DiLallo]

  One area investors really need to drill deeper into is the company's reserve base, which will give you a better idea of how it's producing the income needed to support the large distribution. Today, we're going to drill down into the reserves of EV Energy Partners (NASDAQ: EVEP  ) to get a better idea of what an investor is actually buying when adding units to their portfolio.

Hot Gas Companies To Watch In Right Now: HRT Participacoes em Petroleo SA (HRTPY.PK)

HRT Participacoes em Petroleo SA, formerly BN 16 Participacoes Ltda, is a Brazil-based holding company engaged in the oil and gas industry. The Company is primarily involved in the exploration and production (E&P) of oil and natural gas in Brazil and Namibia. Through its subsidiaries, it is active in the geophysical and geological research, exploration, development, production, import, export and sale of oil and natural gas, as well as in the provision of air logistics services in transporting people and equipment related to oil and gas activities in the exploratory campaign in the Solimoes Basin. As of December 31, 2011, the Company had seven subsidiaries, including Integrated Petroleum Expertise Company Servicos em Petroleo Ltda (IPEX), HRT O&G Exploracao e Producao de Petroleo Ltda, HRT Netherlands BV, HRT America Inc, HRT Africa, HRT Canada Inc and Air Amazonia Servicos Aereos Ltda.

Advisors' Opinion:

• [By stanh30]

  In 2010 Brazil�� HRT Participacoes em Petroleo S.A. (HRTPY.PK) raised $1.5 billion in an IPO to fund a highly touted and highly expensive oil & gas exploration campaign in both the Amazon and offshore Namibia. Management was very promotional and overpromised and underdelivered. The three exploration wells in Namibia were all failures and the Conclusion of Solimoes Gas Monetization Study leads the market (myself included) to conclude that there is little or no present value in the discoveries in the Solimoes basin. The stock has lost 85% in just the last year, and over 97% in the last three years. Early investors like Southeastern Asset Management have lost most of their money and have either given up or believe the market cap has become too small and insignificant to warrant further examination.

Hot Gas Companies To Watch In Right Now: InterOil Corp (IOC)

InterOil Corporation (InterOil), incorporated on August 24, 2007, is an integrated energy company operating in Papua New Guinea and the surrounding Southwest Pacific region. InterOil operates in four segments: upstream, midstream, downstream and corporate. The upstream segment explores, appraises and develops crude oil and natural gas structures in Papua New Guinea. This segment also manages its construction business, which services the development projects underway in Papua New Guinea. The midstream segment produces refined petroleum products at Napa Napa in Port Moresby, Papua New Guinea for the domestic market and for export. It is developing liquefaction and associated facilities in Papua New Guinea for the export of liquefied natural gas (LNG). The downstream segment markets and distributes refined products domestically in Papua New Guinea on a wholesale and retail basis.

During 2012, it sold approximately 13% of its refined petroleum products to Pacific Energy Aviation (PNG) Ltd for aviation refueling at Papua New Guinea�� international airport in Port Moresby. The corporate segment provides support to the other business segments by engaging in business development and improvement activities and providing general and administrative services and management, undertakes financing and treasury activities, and is responsible for government and investor relations. This segment also manages the Company�� shipping business, which operates two vessels transporting petroleum products for it�� and external customers, both within PNG and for export in the South Pacific region.

Upstream - Exploration and Production

InterOil�� upstream business segment focuses on the development program for the Elk, Antelope and Triceratops fields. The Elk and Antelope fields are onshore gas fields with contingent resources. As at December 31, 2012, it had interests in three PPLs and one PRL in Papua New Guinea covering 3,996,453 gross acres, all of which were operated by the Co! mpany. PPLs 236, 237 and 238 and PRL 15 are located onshore in the Eastern Papuan Basin, northwest of Port Moresby. It undertook exploration activities in its three exploration licenses, PPL 236, PPL 237 and PPL 238. These exploration activities involved a regional airborne geophysical survey, various seismic surveys across a number of prospects and preparation for drilling of its next appraisal well, Triceratops 2, which was spudded in mid-January 2012.

As of December 31, 2012, the Company had a 100% working interest in PPL 236. The license consists of 53 graticular blocks covering an area of 4,502 square kilometers or 1,112,464 acres. As of December 31, 2012, the Company had a 100% working interest in PPL 237. The license consists of 34 graticular blocks covering an area of 3,238 square kilometers or 715,648 acres. As of December 31, 2012, the Company had a 100% working interest in PPL 238. The license consists of 94 graticular blocks covering an area of 7,922 square kilometers or 1,978,565 acres.

Midstream

The Company�� refinery is located across the harbor from Port Moresby, the capital city of Papua New Guinea. Its refinery is the sole refiner of hydrocarbons located in Papua New Guinea. Jet fuel, diesel and gasoline are the primary products that the Company produces for the domestic market. The refining process also results in the production of two Naphtha grades and low sulfur waxy residue. Papua New Guinea is its principal market for the products its refinery produces, other than Naphtha and LSWR. Its refinery is fully certified to manufacture and market Jet A-1 fuel to international specifications and markets this product to both domestic Papua New Guinea and overseas airlines.

Downstream - Wholesale and Retail Distribution

The Company has the wholesale and retail petroleum product distribution base in Papua New Guinea. This business includes bulk storage, transportation distribution, aviation, wholesale and retail facilities! for refi! ned petroleum products. Its downstream business supplies petroleum products nationally in Papua New Guinea through a portfolio of retail service stations and commercial customers. As of December 31, 2012, InterOil provided petroleum products to 53 retail service stations with 43 operating under the InterOil brand name and the remaining 10 operating under their own independent brand. Of the 53 service stations that the Company supplies, 16 are either owned by or head leased to it, which it then sublease to company-approved operators. The remaining 37 service stations are independently owned and operated. It also provides fuel pumps and related infrastructure to the operators of the majority of these retail service stations that are not owned or leased by the Company under cover of equipment loan agreement. Its retail business accounted for approximately 15% of its total downstream sales during 2012. Its retail and wholesale distribution business distributes diesel, jet fuel, avgas, gasoline, kerosene and fuel oil, as well as branded commercial and industrial lubricants, such as engine and hydraulic oils.

The Company competes with ExxonMobil.

Advisors' Opinion:

• [By Dan Caplinger]

  Outside the Dow, InterOil (NYSE: IOC  ) has soared more than 10% after announcing results for its first quarter. The company, which has extensive natural-gas reserves in Papua New Guinea, recorded lower profit for the quarter on a 3.6% rise in revenue. More important than these results, though, is whether InterOil can secure a partner for its planned liquefied-natural-gas project in the island nation. That will be the key to whether InterOil can get its gas to lucrative Asian markets and cash in on its massive opportunity.

• [By Eric Volkman]

  InterOil (NYSE: IOC  ) results for Q1 have been released. For the quarter, revenues totaled $350 million, up from the $338 million in the same period the previous year. Net profit was just above $4 million ($0.08 per diluted share), less than half of Q1 2012's $9.4 million ($0.19).

• [By Rich Duprey]

  Dance card filling up
  Can a deal finally be at hand that allows InterOil (NYSE: IOC  ) to deliver on the expectations it's promised investors for so long? We've been waiting more than a month for the Papua New Guinea oil-exploration specialist to decide whom it will partner with. The government of the tiny oil outpost demanded that it be a "supermajor" oil company (at the same time it was extracting better terms for itself) as a way of guaranteeing that the oil will actually get drilled, marketed, and sold. Investors have been on tenterhooks since, as InterOil apparently very laboriously goes through the bids it's received.

Hot Gas Companies To Watch In Right Now: Transocean Ltd (RIGN.VX)

Transocean Ltd. (Transocean) is an international provider of offshore contract drilling services for oil and gas wells. The Company operates in two segments: contract drilling services and other operations. Contract drilling services, the Company�� primary business, includes contracting Transocean�� mobile offshore drilling fleet, related equipment and work crews primarily on a day rate basis to drill oil and gas wells. Its other operations segment includes drilling management services, and oil and gas properties. It participates in oil and gas exploration and production activities. In November 2010, it purchased a PPL Pacific Class 400 design High-Specification Jackup, which is under construction at PPL Shipyard Pte Ltd. in Singapore. Subsequent to the year ended December 31, 2010, it completed the sale of the High-Specification Jackup Trident 20. On October 4, 2011, the Company acquired, through Transocean Services AS, Aker Drilling ASA.

During 2010, the Company completed the sale of two Midwater Floaters, GSF Arctic II and GSF Arctic IV. As of February 10, 2011, Transocean owned, had partial ownership interests in or operated 138 mobile offshore drilling units. As of February 10, 2011, Transocean�� fleet consisted of 47 High-Specification Floaters (Ultra-Deepwater, Deepwater and Harsh Environment semisubmersibles and drillships), 25 Midwater Floaters, nine High-Specification Jackups, 54 Standard Jackups and three Other Rigs. In addition, the Company had one Ultra-Deepwater Floater and three High-Specification Jackups under construction. During 2010, the Company completed construction of five Ultra-Deepwater newbuilds, four of which have commenced their respective contracts. As of December 31, 2010, it held 50% interest in Transocean Pacific Drilling Inc. (TPDI), 65% interest in Angola Deepwater Drilling Company Limited (ADDCL) and a 50% interest in Overseas Drilling Limited (ODL).

Drilling Fleet

Transocean principally operates three types of drilling rig! s: drill ships, semisubmersibles and jackups. Also included in its fleet are barge drilling rigs and a coring drillship. Its fleet includes High-Specification Floaters, which consists of the Company�� Ultra-Deepwater Floaters, Deepwater Floaters and Harsh Environment Floaters; Midwater Floaters, High-Specification Jackups, Standard Jackups and Other Rigs. High-Specification Floaters are specialized offshore drilling units that it categorizes into three sub-classifications. Ultra-Deepwater Floaters are equipped with high-pressure mud pumps and are capable of drilling in water depths of 7,500 feet or greater. Deepwater Floaters include other semisubmersible rigs and drillships capable of drilling in water depths between 7,200 and 4,500 feet. Harsh Environment Floaters are capable of drilling in harsh environments in water depths between 5,000 and 1,500 feet and have greater displacement, which offers variable load capacity, useable deck space and better motion characteristics. Midwater Floaters consist of non-high-specification semisubmersibles that have a water depth capacity of less than 4,500 feet. High-Specification Jackups consist of its jackups, and Standard Jackups consist of the Company�� remaining jackup fleet.

As of February 10, 2011, Transocean�� fleet was located in the Far East (29 units), Middle East (17 units), West African countries other than Nigeria and Angola (16 units), United States Gulf of Mexico (14 units), United Kingdom North Sea (13 units), India (11 units), Brazil (10 units), Nigeria (seven units), Norway (five units), Angola (five units), the Mediterranean (three units), the Netherlands (three units), Australia (three units) and Canada (two units). As of February 10, 2011, its four rigs under construction included Deepwater Champion, Transocean Honor, High-Specification Jackup TBN1 and High-Specification Jackup TBN2. As of February 10, 2011, the Company�� Midwater Floaters included Sedco 700, Transocean Amirante, Transocean Legend, GSF Arctic I, C. Kirk Rhe! in, Jr. a! nd GSF Rig 135. As of February 10, 2011, its High-Specification Jackups included GSF Constellation I, GSF Constellation II, GSF Galaxy I, GSF Galaxy II, GSF Galaxy III and GSF Baltic. As of February 10, 2011, the Company�� Standard Jackups included Trident IX, GSF Adriatic II, GSF Adriatic IX, GSF Adriatic X, GSF Key Manhattan, GSF Key Singapore, GSF Adriatic VI and GSF Adriatic VIII.

Contract Drilling Services

Transocean�� primary business is to contract its drilling rigs, related equipment and work crews on a dayrate basis to drill oil and gas wells. Transocean�� contracts to provide offshore drilling services are individually negotiated and vary in their terms and provisions.

Drilling Management Services

The Company provides drilling management services primarily on a turnkey basis through Applied Drilling Technology Inc., its wholly owned subsidiary, which primarily operates in the United States Gulf of Mexico, and through ADT International, a division of one of its United Kingdom subsidiaries, which primarily operates in the North Sea (together, ADTI). ADTI provides oil and gas drilling management services on a dayrate basis or a completed-project, fixed-price (or turnkey) basis, as well as drilling engineering and drilling project management services. As part of its turnkey drilling services, the Company provides planning, engineering and management services. Under turnkey arrangements, it designs and executes of a well and delivers a logged or cased hole to an agreed depth. In addition to turnkey drilling services, Transocean participates in project management operations that include providing certain planning, management and engineering services, purchasing equipment and providing personnel and other logistical services to customers.

Integrated Services

Transocean provides well and logistics services in addition to its normal drilling services through third party contractors and the Company�� employees. These o! ther serv! ices include integrated services. As of February 10, 2011, it was performing such services in India.

Oil and Gas Properties

The Company conducts oil and gas exploration, development and production activities through its oil and gas subsidiaries. It acquires interests in oil and gas properties principally in order to facilitate the awarding of turnkey contracts for Transocean's drilling management services operations. The Company�� oil and gas activities are conducted through Challenger Minerals Inc. and Challenger Minerals (North Sea) Limited (together, CMI), which hold property interests primarily in the United States offshore Louisiana and Texas and in the United Kingdom sector of the North Sea.

Advisors' Opinion:

• [By Anna Prior]

  Among the companies with shares expected to actively trade in Monday’s session are ViroPharma Inc.(VPHM), Transocean Ltd.(RIGN.VX) and Gogo Inc.(GOGO)

Hot Forestry Companies For 2015

Hot Forestry Companies For 2015: Westmoreland Coal Company(WLB)

Westmoreland Coal Company operates as an energy company in the United States. The company, through its subsidiaries, engages in the production and sale of sub-bituminous coal and lignite to electricity generating plants; and the ownership of power plants in North Carolina. It owns 5 surface coal mines in Montana, North Dakota, and Texas; and 2 coal-fired power generating units with a capacity of approximately 230 megawatts in Weldon, North Carolina. As of December 31, 2010, Westmoreland Coal Company had estimated proven and probable coal reserves of 389.9 million tons. The company was founded in 1854 and is headquartered in Englewood, Colorado.

Advisors' Opinion:

• [By Tyler Crowe]

  No. 3: Westmoreland Coal (NASDAQ: WLB  ) , up 67.6%
  Yes, you read that right, a coal company is one of the best-performing energy stocks of the year. When you look at the performance of the major coal companies so far this year, this one really stands out.

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  In trading on Tuesday, energy shares were relative leaders, up on the day by about 1.41 percent. Meanwhile, top gainers in the sector included Stone Energy (NYSE: SGY), up 9 percent, and Westmoreland Coal Co (NYSE: WLB), up 7.8 percent. Industrials services shares gained by just 0.02 percent in Tuesday's trading.

source from Top Stocks For 2015:http://www.topstocksblog.com/hot-forestry-companies-for-2015-2.html

Top Bank Stocks To Own Right Now

Top Bank Stocks To Own Right Now: Ellington Financial LLC (EFC)

Ellington Financial LLC (EFC) is a specialty finance company, which specializes in acquiring and managing mortgage-related assets. As of December 31, 2011, its targeted assets included residential mortgage-backed securities (RMBS), backed by prime jumbo, Alternative A-paper (Alt-A), manufactured housing and subprime residential mortgage loans (non-Agency RMBS); RMBS for which the principal and interest payments are guaranteed by a United States Government agency or a United States Government-sponsored entity (Agency RMBS); mortgage-related derivatives; commercial mortgage-backed securities (CMBS), commercial mortgage loans and other commercial real estate debt, and corporate debt and equity securities and derivatives. It also acquires and manages other types of mortgage-related assets and financial assets, such as residential whole mortgage loans, asset-backed securities (ABS), backed by consumer and commercial assets, non-mortgage-related derivatives and real property.

Non-Agency RMBS

The Company acquires non-Agency RMBS backed by prime jumbo, Alt-A, manufactured housing and subprime residential mortgage loans. Its non-Agency RMBS holdings include investment-grade and non-investment grade classes. Non-Agency RMBS are debt obligations issued by private originators of or investors in residential mortgage loans. Non-Agency RMBS are issued as CMOs and are backed by pools of whole mortgage loans or by mortgage pass-through certificates. Non-Agency RMBS are securitized in senior/subordinated structures, or in excess spread/over-collateralization structures. In senior/subordinated structures, the subordinated tranches absorb all losses on the underlying mortgage loans before any losses are borne by the senior tranches.

Agency RMBS

The Company's assets in this asset class consist of whole pool pass-th! rough certificates, the principal and interest of which are guaranteed by Federal National Mortg age Association (Fannie Mae), Federal Home Loan Mortgage Cor! poration (Freddie Mac), or Government National Mortgage Association (Ginnie Mae), and which are backed by adjustable rate mortgages (ARMs), hybrid ARMs or fixed-rate mortgages. Mortgage pass-through certificates are securities representing undivided interests in pools of mortgage loans secured by real property where payments of both interest and principal, plus pre-paid principal, on the securities are made monthly to holders of the security, in effect passing through monthly payments made by the individual borrowers on the mortgage loans that underlie the securities, net of fees paid to the issuer/guarantor and servicers of the securities. Whole pool pass-through certificates are mortgage pass-through certificates that represent the entire ownership of a pool of mortgage loans.

In addition to investing in specific pools of Agency RMBS, the Company utilizes forward-settling purchases and sales of Agency RMBS where the underlying pools of mortgage loans are to be announced mortgage-backed securities (MBS) (TBAs). Pursuant to these TBA transactions, it agrees to purchase or sell, for future delivery, Agency RMBS with certain principal and interest terms and certain types of underlying collateral. It uses TBAs for hedging purposes. It engages in TBA transactions for purposes of managing certain risks associated with its long Agency RMBS and its non-Agency RMBS.

Mortgage-Related Derivatives

The Company takes long and short positions in various mortgage-related derivative instruments, including credit default swaps. A credit default swap is a credit derivative contract in which one party (the protection buyer) pays an ongoing periodic premium (and often an upfront payment as well) to another party (the protection seller) in return for compensation for default (or similar credit event) by a reference entity. I! n this ca! se, the reference entity can be an individual MBS or an index of several MBS, such as an ABX I ndex, PrimeX or a CMBX Index.

CMBS

CMBS ar! e mortgage-backed securities collateralized by loans on commercial properties. CMBS issued are fixed rate securities backed by fixed rate loans made to multiple borrowers on a range of property types, though single-borrower CMBS and floating-rate CMBS have also been issued. Commercial mortgage loans are loans secured by liens on commercial properties, including retail, office, industrial, hotel and multifamily properties. Commercial real estate loans may also be structured into more complicated senior/subordinate structures, including those providing for multiple B-Note or multiple mezzanine loan senior/subordinate components.

Corporate Debt and Equity Securities and Derivatives

For hedging purposes, the Company takes short positions in corporate debt and equity (including indices on corporate debt and equity) by entering into derivative contracts, such as credit default swaps, total return swaps and options. These hedges reference corporations (su ch as financial institutions that have substantial mortgage-related exposure) or indices whose performance has a degree of correlation with the performance of its portfolio. Given this correlation, a short position with respect to such corporations or indices provides a hedge to its portfolio of MBS as a whole.

Other Assets

The Company from time to time acquires other mortgage-related and financial assets, which include residential whole mortgage loans, ABS backed by consumer and commercial assets and real property. It also acquires real property interests, such as single family and multifamily residential properties.

Advisors' Opinion:

• [By Luke Jacobi]

  Ellington Financial LLC (NYSE: EFC) was down, falling 4.4 percent to $23.53 after the company priced 8 million shares at $23.92 per share.

  Commoditie! s

  Al! though equities have been flat, the same cannot be said for the commodity market. Crude futures shot higher Wednesday, following yesterday’s sharp sell off. At last check, WTI futures were up 2.7 percent to $95.37 and Brent futures gained 2.1 percent to $102.45.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-bank-stocks-to-own-right-now-3.html

5 Best Up And Coming Stocks To Buy Right Now

5 Best Up And Coming Stocks To Buy Right Now: TriQuint Semiconductor Inc.(TQNT)

TriQuint Semiconductor, Inc. provides radio frequency (RF) solutions and technology for communications, defense, and aerospace companies worldwide. The company designs, develops, and manufactures RF solutions with gallium arsenide (GaAs), gallium nitride, bipolar high electron mobility transistor, surface acoustic wave (SAW), temperature compensated surface acoustic wave, bulk acoustic wave (BAW), copper flip, and wafer level packaging technologies. The company offers an array of filtering, switching, and amplification products for RF, microwave, and millimeter-wave applications. It sells electronic components for mobile phones, including transmit modules, RF filters, power amplifiers and power amplifier modules, duplexers, switches, other RF devices, and integrated products to mobile device manufacturers. The company also offers signal amplification and filtering products, including a portfolio of GaAs microwave monolithic integrated circuits and transistors, and SAW and BAW filter components that support the transfer of voice, data, and video across wireless or wired infrastructure. Its network products comprise millimeter wave power amplifiers, frequency converters, and voltage controlled oscillators. In addition, the company provides defense and aerospace devices, including packaged products, die-level integrated circuits (ICs), microwave monolithic ICs, and multi-chip modules to military contractors serving the U.S. government for use in various communications and phased array radar programs, such as ship-based, airborne, and battlefield systems, as well as sat-com, electronic warfare, and guidance applications. Further, TriQuint Semiconductor, Inc. offers foundry services. The company sells its products through independent manufacturers? representatives, independent distributors, and direct sales staff. TriQuint Se! miconductor, Inc. was founded in 1981 and is headquartered in Hillsboro, Oregon.

Advisors' Opinion:

• [By Dan Caplinger]

  2. Go with a broader approach
  Because the January Effect theory says that small-cap stocks tend to outperform large-cap stocks early in the year, ETFs like the iShares Russell 2000 ETF (NYSEMKT: IWM  ) are a natural choice for those who don't feel comfortable picking individual stocks in the small-cap space. The iShares ETF tracks the popular Russell 2000 index of small-cap stocks, owning more than 2,000 small-cap names and managing more than $30 billion in assets. It's among the most liquid small-cap-oriented ETFs available, and it comes with a modest expense ratio of just 0.2% annually. With names like ISIS Pharmaceuticals (NASDAQ: ISIS  ) and Triquint Semiconductor (NASDAQ: TQNT  ) among its top holdings, the ETF has broad-based exposure to some of the top performers in the small-cap space.

• [By Timothy Green]

  RF Micro Devices (NASDAQ: RFMD  ) and TriQuint Semiconductor (NASDAQ: TQNT  ) are merging into a new company, called Qorvo, with the deal set to close on Dec. 31. This year has been a great one for RF Micro, with the stock price soaring on the back of rising revenue and profits, and the merger promises both synergies and advantages from increased scale.

source from Top Stocks For 2015:http://www.topstocksblog.com/5-best-up-and-coming-stocks-to-buy-right-now-4.html

10 Best Biotech Stocks To Own Right Now

Keryx (NASDAQ: KERX  ) is a development-stage biotech company currently awaiting approval of its NDA�for phosphate binder drug Zerenex (ferrous citrate).�This niche kidney failure space, which generated more than $1 billion in annual sales in 2009, already includes a few major contenders to Zerenex.

These heavy hitters include Sanofi's (NYSE: SNY  ) Renagel, Fresenius' Phoslo, and generic calcium acetate versions of Phoslo. Additionally, Impax Laboratories (NASDAQ: IPXL  ) intends to market a generic sevelamer product following for Renagel's 2014 patent expiration.

A major splash from Zerenex in the phosphate binder arena would likely pull significant market share away from these contenders. Impax in particular has much to lose given wavering earnings confidence among investors who see new generic product opportunities as an avenue back to brighter days.

With these major competitors already occupying the space, investors should be asking what, if anything, gives Zerenex a clinical advantage in this highly competitive market?

5 Best High Tech Stocks To Own For 2015: Stemline Therapeutics Inc (STML)

Stemline Therapeutics, Inc. (Stemline), incorporated on August 8, 2003, is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics that target both cancer stem cells (CSCs) and tumor bulk. The Company is developing two clinical-stage product candidates, SL-401 and SL-701, for which it holds global marketing rights. The indication for SL-401, a biologic-drug conjugate, is acute myeloid leukemia (AML). The indications for SL-701, a synthetic peptide vaccine, are pediatric and adult brain cancer. It has a platform, StemScreen, for the discovery of CSC-targeted compounds, from which it has discovered or validated several of its clinical and preclinical product candidates. Stemline�� StemScreen consists of StemScreen-1 and StemScreen-2 for the identification of CSC-directed compounds.

SL-301 is a small molecule gamma-secretase inhibitor that inhibits Notch, a pathway expressed by CSCs and tumor bulk of multiple cancer types. SL-101 is a monoclonal antibody-based (mAb -based) compound that targets CD123 and has shown in vitro activity against certain hematologic cancers. SL-201 is a small molecule active against certain hematologic and solid tumor types. SL-601 is a mAb-based compound that targets a cell surface marker on bladder CSCs, which is also expressed on a variety of other solid tumor types. It has also in-licensed certain intellectual property directed to mAb-based therapeutics to validated oncology targets, including Glypican-3, Tie-1, CD133, Frizzled, Smoothened and Patched.

SL-401 - An IL-3R-Directed Compound Targeting Cancer Stem Cells and Tumor Bulk

SL-401 is a clinically active biologic-drug conjugate consisting of human interleukin-3 (IL-3) genetically linked to a truncated version of diphtheria toxin. SL-401 targets the IL-3 receptor (IL-3R), which is overexpressed on both the CSCs and tumor bulk of multiple hematologic cancers, including AML. SL-401 has demonstrated preclinical in vit! ro and in vivo activity against both leukemia blasts (which includes tumor bulk) and CSCs of a range of human leukemia cell lines and primary leukemia cells from patients.

SL-701

SL-701 is a clinically active synthetic peptide vaccine that targets several epitopes on CSCs and tumor bulk of brain cancer. In two completed Phase 1/2 clinical trials, SL-701 demonstrated single agent anti-tumor activity in pediatric patients with newly diagnosed brainstem glioma (BSG) and other high-grade gliomas (HGGs) and in adult patients with refractory or recurrent GBM, and other HGGs.

StemScreen-1

StemScreen-1 is a drug discovery platform designed to identify CSC-targeted compounds based on the isolation of CSCs and evaluation of CSC gene expression profiles. CSCs are isolated from primary tumor tissue or cell lines, and then subjected to gene expression analysis using a variety of technologies, including microarray. A control tissue, such as normal bone marrow is analyzed as a comparator against the gene expression profile of the isolated CSCs. These data are then interfaced with an information base of compounds and their mechanisms of action (that is which gene products and pathways they impact). It has utilized StemScreen-1 to discover a number of its preclinical drug candidates. These include SL-201, SL-301, and SL-601. In addition, SL-401 demonstrated activity against CSCs as determined by both an in vitro colony formation and in vivo animal implantation assay, thereby validating certain StemScreen-1 anti-CSC assays.

StemScreen-2

StemScreen-2 is a high throughput drug discovery platform it is developing to discover anti-CSC compounds. StemScreen-2 utilizes a cell-based assay that can track and follow CSCs in their natural state during high throughput screening. In particular, StemScreen-2 utilizes a CSC-specific promoter linked to a reporter as a method for identifying and following CSCs in their native environment of surrounding tumor b! ulk. In t! his way, StemScreen-2 enables the identification of compound hits, in a high throughput manner, with anti-CSC activity.

The Company competes with Boston Biomedical, Inc., Eclipse Therapeutics, Inc., OncoMed Pharmaceuticals, Inc., Verastem, Inc., Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Dainippon Sumitomo Pharma Co. Ltd., Geron Corp., GlaxoSmithKline plc, ImmunoCellular Therapeutics, Ltd, Macrogenics Inc., Amgen, Inc., Pfizer Inc., Roche Holding AG, Sanofi U.S. LLC., Cyclacel Pharmaceuticals, Inc., Sunesis Pharmaceuticals Inc., Clavis Pharma ASA, Ambit Biosciences Corporation, Celgene Corporation, Eisai Co. Ltd., Celator Pharmaceuticals, Inc., Merck & Co., Inc., Eisai Co., Inc., Roche Holding AG, Novartis AG and Celldex Therapeutics, Inc.

Advisors' Opinion:

• [By David Zeiler]

  3. Stemline Therapeutics Inc. (Nasdaq: STML): This biotech develops drugs that target cancer stem cells and tumors. Stemline went public January 29 at $10 a share and rose just 11.78% on its first day. But STML has climbed steadily since, and currently trades at $37.46, up 274.6% from its IPO price.

• [By Keith Speights]

  Best-performing biotech IPO
  Stemline Therapeutics� (NASDAQ: STML  ) has only traded publicly this year, but what a year it's been. The stock's performance ranks Stemline as the best-performing biotech IPO so far in 2013. This week has been pretty good also, with shares moving up by 28%.

10 Best Biotech Stocks To Own Right Now: OvaScience Inc (OVAS)

OvaScience, Inc., incorporated on April 5, 2011, is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells. The Company holds license from Massachusetts General Hospital (MGH) to an issued patent and various patent applications directed to methods of identifying and purifying egg precursor cells, compositions comprising egg precursor cells and methods of using egg precursor cells to treat infertility and related disorders. The Company�� product candidates are AUGMENT and OvaTure. The Company�� designs AUGMENT to treat infertility due to poor egg quality.

The Company�� first product candidate is AUGMENT, stands for autologous germline mitochondria energy transfer. It designs AUGMENT to increase the success of in vitro fertilization (IVF) by isolating fresh mitochondria from a woman's own egg precursor cells and then adding the mitochondria into the woman's egg during IVF. Its second product candidate is OvaTure. OvaTure involves the creation of mature fertilizable eggs from a woman's own egg precursor cells. If successful, this would allow women with compromised eggs due to age or other factors to undergo IVF using their own higher quality eggs.

The Company competes with Novocellus Ltd., Auxogyn, Inc, and Ovacyte LLC.

Advisors' Opinion:

• [By John Udovich]

  On Thursday, small cap infertility stock OvaScience Inc (NASDAQ: OVAS) surged 23.63% plus shares are up 372.9% since the start of the year���meaning its worth taking a closer look at the stock along with the performance of female or reproductive health stocks the Female Health Co (NASDAQ: FHCO) and�Utah Medical Products, Inc (NASDAQ: UTMD)�along with the Vanguard Health Care ETF (NYSEARCA: VHT).

10 Best Biotech Stocks To Own Right Now: Five Prime Therapeutics Inc (FPRX)

Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. Protein therapeutics is antibodies or drugs developed from extracellular proteins or protein fragments that block disease processes, including cancer and inflammatory diseases. The Company�� advanced product candidates include FP-1039/GSK3052230 (FP-1039), FPA008 and FPA144. FP-1039 is a protein therapeutic that traps and neutralizes cancer-promoting fibroblast growth factors (FGFs), involved in cancer cell proliferation and new blood vessel formation. FPA008 is an antibody that inhibits colony stimulating factor-1 receptor (CSF1R), and is being developed to treat patients with inflammatory diseases, including rheumatoid arthritis (RA). FPA144 is an antibody that inhibits FGF receptor 2b (FGFR2b), and is being developed to treat patients with gastric cancer and potentially other solid tumors.

FP-1039

FP-1039 is a protein therapeutic, which includes the extracellular part of FGFR1. FP-1039 acts as an inhibitor of FGFs, because the FGFR1 portion of the molecule binds to FGFs and prevents them from binding to FGFR1 on tumor and blood vessel cells. Because FGF proteins circulating in the blood are called ligands, FP-1039 is called a ligand trap. FP-1039 also includes a portion of an antibody called the Fc region. In preclinical testing, it observed inhibition of tumor growth with single-agent FP-1039, particularly in tumors withFGFR1 gene amplification, including squamous NSCLC and SCLC.

FPA008

FPA008 is an antibody that inhibits CSF1R and is being developed to treat patients with RA. FPA008 also has the potential to treat patients with other inflammatory diseases, including lupus nephritis, psoriatic arthritis, ankylosing spondylitis, fibrosis, inflammatory bowel disease and multiple sclerosis. These are chronic, incurable disorders with serious medical complications and disability for ! which better therapies with novel mechanisms of action are needed. FPA008 is an anti-CSF1R antibody, which it designed to block the ability of IL-34 and CSF1 to bind to and activate CSF1R. FPA008 reduces the numbers and activity of monocytes and macrophages that cause disease, and prevents the production and release of inflammatory factors. The Company and others has demonstrated that both IL-34 and CSF1 are present at increased levels in the inflamed joints of patients with RA.

FPA144

FPA144 is a monoclonal antibody directed against a form of FGFR2, or FGFR2b. When the FGFR2 gene is amplified by cancer cells, the FGFR2b protein is expressed at abnormally high levels on the tumor�� surface. This occurs in some patients with gastric and lower esophageal cancers. The tumor cells that have too much FGFR2b protein on their surface can be identified by special staining tests performed on the tumor. Because FGFR2b is the target for FPA144, patients��tumors can be screened for this protein, helping to identify the patients most likely to respond to FPA144 treatment.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Alcoa (NYSE: AA) is investing US$13 million to expand its wheel manufacturing plant in Europe, to meet growing demand for its lightweight, durable, low-maintenance aluminum truck wheels. To read the full news, click here. L & L Energy (NASDAQ: LLEN) announced today that its Special Independent Committee has appointed Mr. Nicholas Chen, Managing Partner at Pamir Law Group, to replace Mr. Mark Bartlett. To read the full news, click here. Five Prime Therapeutics (NASDAQ: FPRX) and Bristol-Myers Squibb (NYSE: BMY) announced today that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies directed toward targets identified in two undisclosed immune checkpoint pathways using Five Prime's proprietary target discovery platform. To read the full news, click here. First Solar (NASDAQ: FSLR) on Sunday announced the completion of the 1.3MW(DC) solar photovoltaic (PV) power plant at Kitakyushu-shi. Powered by First Solar FS Series 3 Black PV modules, the plant will generate approximately 1,400 MWh of clean and safe solar electricity per year. To read the full news, click here.

  Posted-In: Credit Suisse US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By John Kell and Tess Stynes var popups = dojo.query(".socialByline .popC"); p]

  Among the companies with shares expected to actively trade in Monday’s session are Keurig Green Mountain Inc.(GMCR), JA Solar Holdings Co.(JASO) and Five Prime Therapeutics Inc.(FPRX)

• [By Monica Gerson]

  Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares dropped 1.13% to $22.68 in pre-market trading after the company priced 3.41 million share offering at $22.00 per share.

10 Best Biotech Stocks To Own Right Now: ImmunoCellular Therapeutics Ltd (IMUC)

ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).

The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.

The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.

Advisors' Opinion:

• [By Monica Gerson]

  ImmunoCellular Therapeutics (NYSE: IMUC) dropped 11.05% to $1.3699. ImmunoCellular's trailing-twelve-month ROE is -59.80%.

  Posted-In: market losersNews Movers & Shakers Intraday Update Markets

• [By Wallace Witkowski]

  Shares of ImmunoCellular (IMUC) �jumped after the drug developer said data on a mid-stage brain cancer drug study were looking encouraging.

10 Best Biotech Stocks To Own Right Now: Provectus Pharmaceuticals Inc (PVCT)

Provectus Pharmaceuticals, Inc., incorporated on May 1, 1978, is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10. The Company has transferred all its intellectual property related to over the counter (OTC) products and non-core technologies to its subsidiaries and designated, such subsidiaries as non-core to its primary business of developing its oncology and dermatology prescription drug candidates. The Company focuses on developing its prescription drug candidates PV-10 and PH-10. The Company is developing PV-10 for treatment of several life threatening cancers, including metastatic melanoma, liver cancer, and breast cancer. The Company is developing PH-10 to provide minimally invasive treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema. All of the Company's prescription drug candidates are in either the pre-clinical or clinical trial stage.

PV-10

As of December 31, 2011, the Company is developing PV-10, a sterile injectible form of rose bengal disodium (Rose Bengal), for direct injection into tumors. Its PV-10 is retained in diseased or damaged tissue but dissipates from healthy tissue. The Company had conducted Phase I and Phase IIstudies of PV-10 for the treatment of metastatic melanoma, and Phase I studies of PV-10 for the treatment of liver and breast cancers.

PH-10

The Company�� prescription drug candidate PH-10 is an aqueous hydrogel formulation of Rose Bengal for topical administration to the skin. The Company is developing PH-10 for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis. In August 2011, the Company completed follow-up of all Phase IIc patients.

Over-the-Counter Pharmaceuticals

The Company had desi! gnated its subsidiary that holds its OTC products, GloveAid and Pure-ific, Pure-Stick, Pure N Clear as non-core. The Company�� GloveAid is a hand cream with both antiperspirant and antibacterial properties, for the comfort of users��hands during and after the wearing of disposable gloves. Its Pure-ific line of products includes two quick-drying sprays, Pure-ific and Pure-ific Kids, that immediately kill up to 99.9% of germs on skin and prevent regrowth for six hours. Pure-ific products prevent the spread of germs and thus complement its other OTC products designed to treat irritated skin or skin conditions, such as acne, eczema, dandruff and fungal infections. Its Pure-ific sprays have been designed with convenience in mind and are targeted towards mothers, travelers, and anyone concerned about the spread of sickness-causing germs.

The Company�� acne products Pure-Stick and Pure N Clear work by decreasing the production of fats, oils and sweat that create an environment conducive to unchecked growth of bacteria. Secondly, the products also act to reduce the number bacteria already present. The Pure-Stick and Pure N Clear are applied topically to affected areas there are no safety concerns with healthy skin.

Advisors' Opinion:

• [By Luke Jacobi]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.38 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.

• [By Jake L'Ecuyer]

  Provectus Biopharmaceuticals (NYSE: PVCT) was also down, falling 3.02 percent to $3.01, letting out some air after the company's opening on the NYSE Friday.

10 Best Biotech Stocks To Own Right Now: Insys Therapeutics Inc (INSY)

Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company�� pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company�� product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).

Subsys

The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.

Dronabinol Product Family

The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.

Cancer Therapeutics

In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.

The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.

Advisors' Opinion:

• [By Roberto Pedone]

  One specialty pharmaceutical player that's quickly moving within range of triggering a big breakout trade is Insys Therapeutics (INSY), which develops and commercialize supportive care products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. This stock is off to a monster start in 2013, with shares up a whopping 434%.

  >>5 Stocks Insiders Love Right Now

  If you take a look at the chart for Insys Therapeutics, you'll notice that this stock has been uptrending strong for the last six months, with shares soaring higher from its low of $9.30 to its recent high of $53.64 a share. During that uptrend, shares of INSY have been making mostly higher lows and higher highs, which is bullish technical price action. Shares of INSY have recently pulled back to its 50-day moving average and the stock has now started to spike higher off that level. That spike is starting to push shares of INSY within range of triggering a big breakout trade.

  Traders should now look for long-biased trades in INSY if it manages to break out above some near-term overhead resistance levels at $43.50 to $44.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 235,266 shares. If that breakout hits soon, then INSY will set up to re-test or possibly take out its next major overhead resistance levels at $47.25 to its all-time high at $53.64 a share.

  Traders can look to buy INSY off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support at $38.75 a share or near its 50-day at $36.73 a share. One can also buy INSY off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Chris Preston]

  INSYS Therapeutics (INSY) is one recent IPO that jumps out. The Arizona-based pharmaceutical company markets a synthetic marijuana drug to treat cancer pain. It went public in May at $8 per share. It opened at over $46 per share.

• [By Monica Gerson]

  INSYS Therapeutics (NASDAQ: INSY) is projected to report its Q1 earnings at $0.28 per share on revenue of $45.63 million.

  Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

10 Best Biotech Stocks To Own Right Now: OncoSec Medical Inc (ONCS)

OncoSec Medical Incorporated, incorporated on February 8, 2008, is an emerging drug-medical device company. The Company focused on designing, developing and commercializing medical approaches for the treatment of solid cancers. In March 2011, the Company acquired from Inovio Pharmaceuticals, Inc. (Inovio) certain assets related to the use of drug-medical device combination products for the treatment of different cancers.

The Company�� acquired assets relate to certain non-deoxyribonucleic acid (DNA) vaccine technology and property relating to selective tumor ablation technologies, which it refers to as the OncoSec Medical System (OMS), a therapy which uses an electroporation device to facilitate delivery of chemotherapy agents, or nucleic acids encoding cytokines, into tumors and/or surrounding tissue for the treatment and diagnosis of various cancers. As of January 24, 2012, the Company had not generated any revenue from operations.

Advisors' Opinion:

• [By John Udovich]

  Small cap biotech stocks AVEO Pharmaceuticals, Inc (NASDAQ: AVEO), OncoSec Medical Inc (OTCMKTS: ONCS) and MetaStat Inc (OTCBB: MTST) are focused on or are developing treatments or diagnostic technologies for metastatic cancers. In case you aren�� familiar with the term metastasis or metastatic, it�� the�spread of cancer from its primary site to other places in the body as cancer cells break away from a primary tumor, penetrate into lymphatic and blood vessels, circulate through the bloodstream and then grow in a new focus (metastasize) in normal tissues elsewhere in the body. In other words, it�� a dangerous form of cancer, but there are some small cap biotech stocks targeting it for diagnostics or treatment:

• [By James E. Brumley]

  If you're looking for the next big biotech breakout stock, then OncoSec Medical Inc. (OTCMKTS:ONCS) deserves a place on your watchlist. This volatile cancer play has been down more than up 2011, but if you look closely at a long-term chart of ONCS, you may find it's already wiggled its way into a new uptrend. And, it may be only a matter of time before the bullish fireworks start to go off.

• [By James E. Brumley]

  How does the old saying go? Beggars can't be choosers? Two weeks ago, yours truly penned some bullish comments regarding OncoSec Medical Inc. (OTCMKTS:ONCS). The long and short of it was, if ONCS could clear a technical ceiling around $0.36, then life would get much easier for the bulls.

• [By Bio-Wire]

  Another company that has benefitted from Inovio�� newfound attention is OncoSec Medical (OTC: ONCS) ��a newer ��ffshoot�� company that uses a similar but distinctly different electroporation device known as the OncoSec Medical System (OMS) that is based on Inovio�� technology. The specific amplitude and frequency of the OMS electroporation is calibrated such that plasmid delivery into solid tumor masses is fully optimized, while CELLECTRA electroporation is less specialized and focus more on the vaccination of skin cells. The cross-license agreement made between Inovio and Oncosec also covers the two devices for their distinctly different applications.

Top Chemical Stocks To Buy Right Now

Top Chemical Stocks To Buy Right Now: PPG Industries Inc.(PPG)

PPG Industries, Inc. manufactures and supplies protective and decorative coatings. The company offers coatings products for automotive and commercial transport/fleet repair and refurbishing, specialty coatings for signs, and light industrial coatings; and sealants, coatings, and technical cleaners/transparencies for commercial, military, regional jet, general aviation aircraft, and transparent armor for military land vehicles. It also provides coatings and finishes for the protection of metals and structures to metal fabricators, heavy duty maintenance contractors, and manufacturers of ships, bridges, rail cars, and shipping containers; and coatings to painting and maintenance contractors. In addition, PPG sells industrial and automotive coatings to manufacturing companies; adhesives and sealants for the automotive industry; metal pretreatments and related chemicals; and coatings and inks for aerosol, food, and beverage containers. Further, it supplies lenses, sunlenses, a nd optical lens materials; amorphous precipitated silicas for tire and battery separator markets; and Teslin substrate used in radio frequency identification tags and labels, e-passports, drivers? licenses, and identification cards applications. Additionally, PPG offers chlor-alkali and derivative products, such as chlorine, caustic soda, vinyl chloride monomer, chlorinated solvents, calcium hypochlorite, ethylene dichloride, hydrochloric acid, and phosgene derivatives to chemical processing, rubber and plastics, paper, minerals, metals, and water treatment industries. It also produces flat glass and continuous-strand fiber glass for commercial and residential construction, wind energy, energy infrastructure, transportation, and electronics industries. PPG sells its products through company-owned stores, home centers, paint dealers, and independent distributors, as well as dir! ectly to customers worldwide. The company was founded in 1883 and is headquartered in Pittsburgh, P e nnsylvania.

Advisors' Opinion:

• [By Laura Brodbeck]

  Thursday

  Earnings Expected From:Verizon Communications Inc., UnitedHealth Group Incorporated, Schlumberger N.V. , PPG Industries, Inc. (NYSE: PPG), Philip Morris International Inc., Goldman Sachs Group, Inc., Google Inc., Chipotle Mexican Grill, Inc. Economic Releases Expected: Italian trade balance, eurozone CPI, US manufacturing production, US industrial production, US oil inventory data

  Friday

• [By Laura Brodbeck]

  Thursday

  Earnings Expected From: SAP AG (NYSE: SAP), Novartis AG (NYSE: NVS), UnitedHealth Group Incorporated (NYSE: UNH), Mattel, Inc, (NASDAQ: MAT), Key Corp (NYSE: KEY), Philip Morris International (NYSE: PM), Morgan Stanley (NYSE: MS), PPG Industries, Inc (NYSE: PPG), The Blackstone Group L.P. (NYSE: BX), Schlumberger N.V. (NYSE: SLB), International Business Machines (NYSE: IBM), Google Inc. (NASDAQ: GOOG) Economic Releases Expected:  Chinese house prices, US housing starts, eurozone CPI, Hong Kong’s unemployment rate

  Friday

• [By Anna Prior]

  PPG Industries Inc.(PPG) agreed to acquire architectural and industrial coatings company Consorcio Comex SA for $2.3 billion. PPG Chief Executive Charles E. Bunch said the acquisition is complementary to the paint and coatings maker’s business.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-chemical-stocks-to-buy-right-now-6.html